1
|
Badruddoza AZM, Zahid MI, Walsh T, Shah J, Gates D, Yeoh T, Nurunnabi M. Topical drug delivery by Sepineo P600 emulgel: Relationship between rheology, physical stability, and formulation performance. Int J Pharm 2024; 658:124210. [PMID: 38718972 DOI: 10.1016/j.ijpharm.2024.124210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2024] [Revised: 04/09/2024] [Accepted: 05/05/2024] [Indexed: 05/12/2024]
Abstract
The objective of this present work was to develop and optimize oil-in-water (O/W) emulsion-based gels, namely emulgels that allow maximum topical drug delivery while having desired microstructure and acceptable physical stability. Emulgels containing 2.0 wt% lidocaine were prepared using various concentrations (0.75-5.0 wt%) of Sepineo P600. Their droplet size distribution, physical stability, rheological behaviors, in vitro drug release, and skin permeation profiles were evaluated. Results show that the concentration of Sepineo P600 significantly influenced the microstructure, rheology, and physical stability of the emulgel formulations. The physico-chemical properties also reveals that at least 1.0 wt% Sepineo P600 was needed to produce stable emulgel formulations. All formulations exhibited non-Newtonian shear-thinning properties which are desirable for topical applications. Both the release and permeation rates decreased with increasing viscosity and rigidity of the formulation. The lower the complex modulus of the emulgels, the higher the steady-state flux of the drug through the skin. Adding Sepineo P600 to emulgel systems resulted in increased rheological properties, which in turn slowed the diffusion of the drug for in vitro release. Although as expected skin permeation was rate limiting since in vitro release was 3 to 4 log-fold faster than skin flux. However, an interesting finding was that the derived skin/vehicle partition coefficient suggested the ionic interaction between lidocaine and Sepineo polymer reducing the free drug, i.e., thermodynamic activity and hence the flux with increasing Sepineo P600 concentration. Overall, this study has provided us with valuable insights into understanding the relationship between the microstructure (rheology), physical stability and skin drug delivery properties which will help to design and optimize topical emulgel formulations.
Collapse
Affiliation(s)
- Abu Zayed Md Badruddoza
- Pharmaceutical Sciences Small Molecule, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.
| | - Md Ikhtiar Zahid
- The Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas at El Paso, El Paso, TX 79902, USA
| | - Taylor Walsh
- Eurofins Lancaster Laboratories Professional Scientific Services, Lancaster, PA 17601, USA
| | - Jaymin Shah
- Pharmaceutical Sciences Small Molecule, Pfizer Worldwide Research and Development, Groton, CT 06340, USA
| | - Dana Gates
- Pharmaceutical Sciences Small Molecule, Pfizer Worldwide Research and Development, Groton, CT 06340, USA
| | - Thean Yeoh
- Pharmaceutical Sciences Small Molecule, Pfizer Worldwide Research and Development, Groton, CT 06340, USA
| | - Md Nurunnabi
- The Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas at El Paso, El Paso, TX 79902, USA.
| |
Collapse
|
2
|
Gates D, Badruddoza AZM, Zahid MI, Yeoh T, Shah J, Walsh T, Nurunnabi M. Sustainable Alternatives to Petroleum-Derived Excipients in Pharmaceutical Oil-in-Water Creams. AAPS PharmSciTech 2024; 25:68. [PMID: 38538866 DOI: 10.1208/s12249-024-02784-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Accepted: 03/06/2024] [Indexed: 04/24/2024] Open
Abstract
Recently, vast efforts towards sustainability have been made in the pharmaceutical industry. In conventional oil-in-water (O/W) cream formulations, various petroleum-based excipients, namely mineral oil and petrolatum, are commonly used. Natural or synthetic excipients, derived from vegetable sources, were explored as alternatives to petroleum-based excipients in prototype topical creams, with 1% (w/w) lidocaine. A conventional cream comprised of petroleum-derived excipients was compared to creams containing sustainable excipients in terms of key quality and performance attributes, physicochemical properties, and formulation performance. The petrolatum-based control formulation had the highest viscosity of 248.0 Pa·s, a melting point of 42.7°C, a low separation index at 25°C of 0.031, and an IVRT flux of 52.9 µg/cm2/h. Formulation SUS-4 was the least viscous formulation at 86.9 Pa·s, had the lowest melting point of 33.6°C, the highest separation index of 0.120, and the highest IVRT flux of 139.4 µg/cm2/h. Alternatively, SUS-5 had a higher viscosity of 131.3 Pa·s, a melting point of 43.6°C, a low separation index of 0.046, and the lowest IVRT flux of 25.2 µg/cm2/h. The cumulative drug permeation after 12 h from SUS-4, SUS-5, and the control were 126.2 µg/cm2, 113.8 µg/cm2, and 108.1 µg/cm2, respectively. The composition of the oil-in-water creams had influence on physicochemical properties and drug release; however, skin permeation was not impacted. Sustainable natural or synthetic excipients in topical cream formulations were found to be suitable alternatives to petroleum-based excipients with comparable key quality attributes and performance attributes and should be considered during formulation development.
Collapse
Affiliation(s)
- Dana Gates
- Drug Product Design, Worldwide Research, Development and Medical, Pfizer Inc., Groton, Connecticut, 06340, USA.
| | - Abu Zayed Md Badruddoza
- Drug Product Design, Worldwide Research, Development and Medical, Pfizer Inc., Groton, Connecticut, 06340, USA
| | - Md Ikhtiar Zahid
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas at El Paso, 500 West University Ave, El Paso, Texas, 79902, USA
| | - Thean Yeoh
- Drug Product Design, Worldwide Research, Development and Medical, Pfizer Inc., Groton, Connecticut, 06340, USA
| | - Jaymin Shah
- Drug Product Design, Worldwide Research, Development and Medical, Pfizer Inc., Groton, Connecticut, 06340, USA
| | - Taylor Walsh
- Eurofins Lancaster Laboratories Professional Scientific Services, 2425 New Holland Pike, Lancaster, Pennsylvania, 17601, USA
| | - Md Nurunnabi
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas at El Paso, 500 West University Ave, El Paso, Texas, 79902, USA
- Biomedical Engineering Program, College of Engineering, University of Texas at El Paso, El Paso, Texas, 79968, USA
| |
Collapse
|
3
|
Modi D, Jonnalagadda S, Campbell GA, Dalwadi G. Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis. J Pharm Sci 2023; 112:2427-2443. [PMID: 36958691 DOI: 10.1016/j.xphs.2023.03.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Revised: 03/16/2023] [Accepted: 03/16/2023] [Indexed: 03/25/2023]
Abstract
This work investigates the micellar titration of phenytoin (a weakly acidic drug) with cetyltrimethylammonium hydroxide (CTAH) to form a hydrophobic ion-pair to enhance oil solubility of phenytoin, followed by an effort to formulate nanoemulsion that could potentially prevent precipitation of phenytoin at physiological pH. The ion-pair formulated in nanoemulsion was evaluated for in vitro precipitation during serial dilution at physiological pH. The formation of ion-pair during titration was explained in context of pH-solubility data. The mathematical model successfully integrated ionization and micellization equilibria to reflect on dominant mechanisms for solubilization. The micellar phenomenon during titration was confirmed using Dynamic Light Scattering (DLS). The phase changes of the excess undissolved solids during titration were evident from X-Ray Powder Diffraction (XRPD) and Fourier Transform Infrared Spectroscopy (FTIR). This analysis confirmed the conversion of phenytoin into ionized state and its subsequent ionic interaction with CTAH forming hydrophobic ion-pair complex (HIP). The complete ion pair formation was evident at pHmax (8.8 to 9.2), and its 1:1 stoichiometry was confirmed using HPLC (Phenytoin and CTAH) and H1 NMR, hence could also be called as a lipophilic salt. The ion-pair (salt) was insoluble in water and showed remarkably high partition coefficient (log P) in octanol/water. As characterized by Hot Stage Microscopy (HSM), the melting point of the ion-pair complex was lowered to 150.8⁰C compared to the free acid (> 300οC), this was even further lowered to 81.1 °C when evaluated in castor oil. This led to approximately eight-fold higher solubility of hydrophobic ion pair (HIP) in castor oil compared to the free acid form. The high miscibility in castor oil was suitable to formulate a high drug load injectable dispersed system. This was successfully achieved with lecithin and polysorbate as emulsifiers without leaching drug into continuous phase at pH 7.4. This nanoemulsion (<300 nm, and > +30 mV zeta potential) remain stable when evaluated over a period of one month. A serial dilution study of the nanoemulsion was performed in PBS buffer, microscopic observations suggested no birefringence despite incubation at 25°C for several hours. This result indicated that Phenytoin remained strongly partitioned within dispersed oily phase with a higher drug loading when ion-paired phenytoin was used. The higher drug load could enable a small volume slow bolus injection to meet 50 mg/min or lower delivery rate criteria for Phenytoin in the clinical set up. This provided a pathway to further explore potential injectable nano-emulsion formulations that could alleviate typical phlebitis issue associated with the injectable phenytoin solution administration at physiological pH.
Collapse
Affiliation(s)
- Dimple Modi
- GlaxoSmithKline, Pharmaceutical Research and Development, Medicinal Science & Technology, 1250 S. Collegeville Road, Collegeville, PA 19426, United States; Saint Joseph's University, Philadelphia, PA 19104, United States
| | | | - Gossett A Campbell
- GlaxoSmithKline, Pharmaceutical Research and Development, Medicinal Science & Technology, 1250 S. Collegeville Road, Collegeville, PA 19426, United States
| | - Gautam Dalwadi
- GlaxoSmithKline, Pharmaceutical Research and Development, Medicinal Science & Technology, 1250 S. Collegeville Road, Collegeville, PA 19426, United States.
| |
Collapse
|
4
|
Badruddoza AZM, Yeoh T, Shah JC, Walsh T. Assessing and Predicting Physical Stability of Emulsion-Based Topical Semisolid Products: A Review. J Pharm Sci 2023; 112:1772-1793. [PMID: 36966902 DOI: 10.1016/j.xphs.2023.03.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2023] [Revised: 03/20/2023] [Accepted: 03/21/2023] [Indexed: 03/30/2023]
Abstract
The emulsion-based topical semisolid dosage forms present a high degree of complexity due to their microstructures which is apparent from their compositions comprising at least two immiscible liquid phases, often times of high viscosity. These complex microstructures are thermodynamically unstable, and the physical stability of such preparations is governed by formulation parameters such as phase volume ratio, type of emulsifiers and their concentration, HLB value of the emulsifier, as well as by process parameters such as homogenizer speed, time, temperature etc. Therefore, a detailed understanding of the microstructure in the DP and critical factors that influence the stability of emulsions is essential to ensure the quality and shelf-life of emulsion-based topical semisolid products. This review aims to provide an overview of the main strategies used to stabilize pharmaceutical emulsions contained in semisolid products and various characterization techniques and tools that have been utilized so far to evaluate their long-term stability. Accelerated physical stability assessment using dispersion analyzer tools such as an analytical centrifuge to predict the product shelf-life has been discussed. In addition, mathematical modeling for phase separation rate for non-Newtonian systems like semisolid emulsion products has also been discussed to guide formulation scientists to predict a priori stability of these products.
Collapse
Affiliation(s)
- Abu Zayed Md Badruddoza
- Drug Product Design, Worldwide Research, Development and Medical, Pfizer Inc., Groton, CT 06340, USA.
| | - Thean Yeoh
- Drug Product Design, Worldwide Research, Development and Medical, Pfizer Inc., Groton, CT 06340, USA
| | - Jaymin C Shah
- Drug Product Design, Worldwide Research, Development and Medical, Pfizer Inc., Groton, CT 06340, USA
| | - Taylor Walsh
- Eurofins Lancaster Laboratories Professional Scientific Services, 2425 New Holland Pike, Lancaster, PA 17601, USA
| |
Collapse
|
5
|
Jacques C, Rattier S, Bianchi P, Angerer TB, Frache G, Cattuzzato L, Perrin L, Villaret A, Duran V, Noharet J, Rouquier A, Bessou-Touya S, Bidan C, Duplan H. In vitro characterization and clinical evaluation of skin hydration by two formulations mimicking the skin's natural components. J Eur Acad Dermatol Venereol 2022; 36 Suppl 5:21-29. [PMID: 35315152 DOI: 10.1111/jdv.17900] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2021] [Revised: 12/01/2021] [Accepted: 12/16/2021] [Indexed: 12/16/2022]
Abstract
BACKGROUND We have developed innovative base formulations that were designed to mimic the skin with respect to its components and galenic structure. Components include water, proteins, lipids, sugars and minerals. OBJECTIVES We characterized formulations and their skin penetration using in vitro methods and evaluated their impact on skin hydration in a clinical trial. METHODS Scanning electron microscopy (SEM) imaging and X-ray diffraction were used to analyse formulations as well as formulation impact on the stratum corneum (SC) structure. Mass spectrometry imaging (MSI) was used to compare formulation ingredients with SC components and to detect their distribution in the skin. Clinical studies were performed to confirm effects on skin hydration and investigate potential adverse skin effects (irritation and sensitization). RESULTS SEM and X-ray diffraction of the formulations showed that lipids were organized in sheets similar to SC lipids. MSI demonstrated similarities between formulation components and skin constituents, as well as a good penetration into the skin. The formulations did not modify the lamellar organization of the SC lipids, but they increased the relative proportion of the crystallized lipids and some of the amorphous lipids. In in vivo studies, a high level of hydration was maintained over 24 h after application with an intense and 'very good hydration'. Both formulations were shown to be non-(photo)sensitizers with excellent tolerance. Sensorial evaluation indicated the formulations were not oily or sticky and maintained the skin's suppleness over time. Formulations had a 'nude skin' touch and created a natural protective film. CONCLUSIONS The two formulations were well-tolerated and increased skin hydration in clinical subjects, an effect that could contribute to the alleviation of sensitive skin. The formulations were shown to resemble the lipid organization of the stratum corneum, as well as penetrate the skin without disrupting the lipid lamella organization.
Collapse
Affiliation(s)
- C Jacques
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - S Rattier
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - P Bianchi
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - T B Angerer
- Luxembourg Institute of Science and Technology (LIST), Advanced Characterization platform, Materials Research and Technology, Belvaux, Luxembourg
| | - G Frache
- Luxembourg Institute of Science and Technology (LIST), Advanced Characterization platform, Materials Research and Technology, Belvaux, Luxembourg
| | - L Cattuzzato
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - L Perrin
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - A Villaret
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - V Duran
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - J Noharet
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - A Rouquier
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - S Bessou-Touya
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - C Bidan
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| | - H Duplan
- Pierre Fabre Dermo-cosmétique, Centre R&D Pierre Fabre, Innovation et Développement Pharmacologie, Toulouse, France
| |
Collapse
|